Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Executive Summary: White Paper on Four Areas of Relevance to New Drug Development and Review in the United States

Therapeutic Innovation & Regulatory Science

Journal indexing and metrics

Journal Homepage Submission guidelines

Restricted access

Other

First published online April, 1995

Executive Summary: White Paper on Four Areas of Relevance to New Drug Development and Review in the United States

Volume 29, Issue 2

https://doi.org/10.1177/009286159502900202

Abstract

Get full access to this article

View all access options for this article.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Restricted access

Degeneration and Dysfunction of Retinal Neurons in Acute Ocular Hypertensive Rats: Involvement of Calpains

Restricted access

i Drugs and i Devices Discovery Research: Preclinical Assays,Techniques,and Animal Model Studies for Ocular Hypotensives and Neuroprotectants

Restricted access

Eyes on New Product Development

Restricted access

The Effects of Commercially Available Preservative-Free FDA-Approved Triamcinolone (Triesence ® ) on Retinal Cells in Culture